Benitec Biopharma's total assets for Q2 2025 were $79.07M, an increase of 14.97% from the previous quarter. BNTC total liabilities were $3.13M for the fiscal quarter, a -31.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.